Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 471

1.

Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation.

Zhang X, Tanaka K, Yan J, Li J, Peng D, Jiang Y, Yang Z, Barton MC, Wen H, Shi X.

Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17284-9. doi: 10.1073/pnas.1307959110. Epub 2013 Oct 7.

2.

Structural insights into estrogen receptor α methylation by histone methyltransferase SMYD2, a cellular event implicated in estrogen signaling regulation.

Jiang Y, Trescott L, Holcomb J, Zhang X, Brunzelle J, Sirinupong N, Shi X, Yang Z.

J Mol Biol. 2014 Oct 9;426(20):3413-25. doi: 10.1016/j.jmb.2014.02.019. Epub 2014 Mar 1.

PMID:
24594358
3.

Gene-specific patterns of coregulator requirements by estrogen receptor-α in breast cancer cells.

Won Jeong K, Chodankar R, Purcell DJ, Bittencourt D, Stallcup MR.

Mol Endocrinol. 2012 Jun;26(6):955-66. doi: 10.1210/me.2012-1066. Epub 2012 Apr 27.

4.

Mixed lineage leukaemia histone methylases 1 collaborate with ERα to regulate HOXA10 expression in AML.

Yao J, Fang LC, Yang ZL, Huang H, Li Y, Deng J, Zheng J.

Biosci Rep. 2014 Dec 8;34(6):e00156. doi: 10.1042/BSR20140116.

5.
6.

G9a-mediated methylation of ERα links the PHF20/MOF histone acetyltransferase complex to hormonal gene expression.

Zhang X, Peng D, Xi Y, Yuan C, Sagum CA, Klein BJ, Tanaka K, Wen H, Kutateladze TG, Li W, Bedford MT, Shi X.

Nat Commun. 2016 Mar 10;7:10810. doi: 10.1038/ncomms10810.

7.

The tale of two domains: proteomics and genomics analysis of SMYD2, a new histone methyltransferase.

Abu-Farha M, Lambert JP, Al-Madhoun AS, Elisma F, Skerjanc IS, Figeys D.

Mol Cell Proteomics. 2008 Mar;7(3):560-72. Epub 2007 Dec 7.

8.

The histone methyltransferase Smyd2 is a negative regulator of macrophage activation by suppressing interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α) production.

Xu G, Liu G, Xiong S, Liu H, Chen X, Zheng B.

J Biol Chem. 2015 Feb 27;290(9):5414-23. doi: 10.1074/jbc.M114.610345. Epub 2015 Jan 12.

9.

ASXL2 promotes proliferation of breast cancer cells by linking ERα to histone methylation.

Park UH, Kang MR, Kim EJ, Kwon YS, Hur W, Yoon SK, Song BJ, Park JH, Hwang JT, Jeong JC, Um SJ.

Oncogene. 2016 Jul 14;35(28):3742-52. doi: 10.1038/onc.2015.443. Epub 2015 Dec 7.

PMID:
26640146
10.

Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis.

Shi L, Sun L, Li Q, Liang J, Yu W, Yi X, Yang X, Li Y, Han X, Zhang Y, Xuan C, Yao Z, Shang Y.

Proc Natl Acad Sci U S A. 2011 May 3;108(18):7541-6. doi: 10.1073/pnas.1017374108. Epub 2011 Apr 18.

11.

Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase.

Subramanian K, Jia D, Kapoor-Vazirani P, Powell DR, Collins RE, Sharma D, Peng J, Cheng X, Vertino PM.

Mol Cell. 2008 May 9;30(3):336-47. doi: 10.1016/j.molcel.2008.03.022.

12.

Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure.

Woodfield GW, Hitchler MJ, Chen Y, Domann FE, Weigel RJ.

Clin Cancer Res. 2009 Jun 1;15(11):3672-9. doi: 10.1158/1078-0432.CCR-08-2343. Epub 2009 May 19.

13.

A novel estradiol/estrogen receptor alpha-dependent transcriptional mechanism controls expression of the human prolactin receptor.

Dong J, Tsai-Morris CH, Dufau ML.

J Biol Chem. 2006 Jul 7;281(27):18825-36. Epub 2006 May 1.

16.

Estrogen receptor alpha represses transcription of early target genes via p300 and CtBP1.

Stossi F, Madak-Erdogan Z, Katzenellenbogen BS.

Mol Cell Biol. 2009 Apr;29(7):1749-59. doi: 10.1128/MCB.01476-08. Epub 2009 Feb 2.

17.

Purification of Histone Lysine Methyltransferase SMYD2 and Co-Crystallization with a Target Peptide from Estrogen Receptor α.

Jiang Y, Holcomb J, Spellmon N, Yang Z.

Methods Mol Biol. 2016;1366:207-217. doi: 10.1007/978-1-4939-3127-9_16.

PMID:
26585137
18.

Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor α-positive breast cancer.

Andruska N, Zheng X, Yang X, Helferich WG, Shapiro DJ.

Oncogene. 2015 Jul;34(29):3760-9. doi: 10.1038/onc.2014.292. Epub 2014 Sep 29.

19.

FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance.

Millour J, Constantinidou D, Stavropoulou AV, Wilson MS, Myatt SS, Kwok JM, Sivanandan K, Coombes RC, Medema RH, Hartman J, Lykkesfeldt AE, Lam EW.

Oncogene. 2010 May 20;29(20):2983-95. doi: 10.1038/onc.2010.47. Epub 2010 Mar 8.

20.

PELP1 is a reader of histone H3 methylation that facilitates oestrogen receptor-alpha target gene activation by regulating lysine demethylase 1 specificity.

Nair SS, Nair BC, Cortez V, Chakravarty D, Metzger E, Schüle R, Brann DW, Tekmal RR, Vadlamudi RK.

EMBO Rep. 2010 Jun;11(6):438-44. doi: 10.1038/embor.2010.62. Epub 2010 May 7.

Supplemental Content

Support Center